Altoida is a neurotechnology company developing a digital diagnostic platform that measures cognitive function using multimodal sensor data, augmented reality tasks, and machine learning analytics. The technology captures hundreds of digital biomarkers in a brief, self-administered assessment designed to reveal subtle cognitive changes not easily detected by traditional clinical methods.

The platform integrates immersive augmented reality activities with advanced data fusion and explainable AI to generate quantitative measures of cognitive performance and function. This approach enables rapid, objective assessments that can potentially support earlier detection of conditions such as mild cognitive impairment and Alzheimer’s disease.

Altoida’s system is intended for use in clinical, research, and healthcare settings to augment diagnostic workflows, support clinical trial enrichment, and monitor cognitive health over time. The company positions its platform as a foundational tool in precision brain health, with potential extensions into broader neurological and neurodegenerative applications.